Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

News [4933]

ASCO 2021: Immunotherapy delays disease recurrence in patients with early-stage, resected non-small cell lung cancer

ASCO 2021: Immunotherapy delays disease recurrence in patients with early-stage, resected non-small cell lung...

ASCO 2021: Dual immunotherapy regimen significantly delays disease progression in patients with advanced melanoma

ASCO 2021: Dual immunotherapy regimen significantly delays disease progression in patients with advanced melanoma

ASCO 2021: Cervical cancer rates drop; other HPV-related cancers are on the rise

ASCO 2021: Cervical cancer rates drop; other HPV-related cancers are on the rise

ASCO 2021: Metabolic inhibitor IACS-6274 shows early anti-tumour effects in underserved patients

ASCO 2021: Metabolic inhibitor IACS-6274 shows early anti-tumour effects in underserved patients

New insights into androgen's action could boost battle against prostate cancer

New insights into androgen's action could boost battle against prostate cancer

Breast cancer treatments do not increase risk of Covid-19 infection or death

Breast cancer treatments do not increase risk of Covid-19 infection or death

Combination therapy achieves high rates of response for patients with ALL

Combination therapy achieves high rates of response for patients with ALL

Combining immunotherapies against cancer

Combining immunotherapies against cancer

New technology makes tumour eliminate itself

New technology makes tumour eliminate itself

'45 is the new 50' as age for colorectal cancer screening is lowered

'45 is the new 50' as age for colorectal cancer screening is lowered

More from ecancer